-
Weeks after the FDA approved the Alzheimer's drug Aduhelm, doctors are struggling to figure out who should get the drug and how to use it safely.
-
The FDA approves new prescribing instructions for Aduhelm to address confusion over who should get the drug, saying it is appropriate for patients with early or mild Alzheimer’s.
-
Gov. Ron DeSantis, speaking at a Jacksonville assisted living facility, says the funding will help support Alzheimer’s research grants at institutions around the state.
-
This is the first new drug approved for Alzheimer's disease since 2003. It's the first to show significant progress against the sticky brain plaques that are the hallmark of Alzheimer's disease.
-
Researchers are looking to enroll 7,600 people for the study into whether computer-based cognitive training can prevent and even improve disorders such as dementia and Alzheimer’s disease.
-
Long-term care residents’ participation in the vaccination effort is clouded by a significant complication: More than half have cognitive impairment or dementia.
-
Researchers launched a major study of an experimental Alzheimer's drug this summer. They also learned a lot about how to protect participants who must make frequent visits to a medical center.
-
Daisy Conant, 91, thrives off routine.One of her favorites is reading the newspaper with her morning coffee. But, lately, the news surrounding the…
-
Structures inside healthy brain cells nimbly move from one state to the next to perform different functions. But in certain degenerative brain diseases, scientists now think, that process gets stuck.
-
Music means a lot to Patricia R. When she sits in her chair and hears the music, she is reminded of her dad. “See, my father had a bar when I was...